Sandler Capital Management’s Zimmer Biomet ZBH Stock Holding History

Sandler Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41,804	Closed	-$4.73M	–	180
2025 Q1	$4.73M	Buy	+41,804	New	+$4.47M	1.18%	27
2017 Q2	–	Sell	-67,258	Closed	-$7.97M	–	208
2017 Q1	$7.97M	Buy	+67,258	New	+$7.62M	0.55%	72
2016 Q2	–	Sell	-101,620	Closed	-$10.5M	–	157
2016 Q1	$10.5M	Buy	+101,620	New	+$9.83M	1.27%	24
2015 Q1	–	Sell	-72,100	Closed	-$7.94M	–	260
2014 Q4	$7.94M	Buy	+72,100	New	+$7.6M	0.42%	83
2014 Q3	–	Sell	-99,601	Closed	-$9.8M	–	236
2014 Q2	$10M	Sell	99,601 -47,380	-32%	-$4.62M	0.42%	93
2014 Q1	$13.5M	Buy	+146,981	New	+$13.5M	0.48%	80

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sandler Capital Management's ZBH Position: Q2 2025 in Review

Sandler Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 41,804 shares — an estimated $4.73M sold.

Sandler Capital Management first reported a position in ZBH in Q1 2014 and held it in 6 quarters. The position peaked at $13.5M in Q1 2014. 939 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Sandler Capital Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
Sandler Capital Management sold 41,804 Zimmer Biomet shares in Q2 2025, an estimated $4.73M.
Sandler Capital Management first reported a position in Zimmer Biomet in Q1 2014 and held it in 6 quarters.
Sandler Capital Management's Zimmer Biomet position peaked at $13.5M in Q1 2014.
939 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Sandler Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.